Intravenous Iron Drugs Market (IV) 2018 Trends, Growth, Size, Opportunities and Global Forecast Discussed in New Research Report
ReportsnReports.com adds “Global Intravenous (IV) Iron Drugs Market: Size, Trends and Forecasts (2018-2022)” report to its research store.
Pune, India – October 31, 2018 /MarketersMedia/ —
The report titled “Global Intravenous (IV) Iron Drugs Market: Size, Trends and Forecasts (2018-2022)”, provides an in depth analysis of the global intravenous (IV) iron drugs market by value, by product, by type, by region, etc. The report also provides a regional analysis of the intravenous (IV) iron drugs market, including the following regions: The US and Europe. The report also provides a detailed analysis of the US intravenous (IV) iron drugs market by value, by products and by indication.
Key Company Coverage: Vifor Pharma AG, Sanofi, AMAG Pharmaceuticals, Inc., Daiichi Sankyo Co., Ltd.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global intravenous (IV) iron drugs market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Purchase a copy of this “Intravenous (IV) Iron Drugs Market” report @ https://www.reportsnreports.com/purchase.aspx?name=1757459.
The global intravenous (IV) iron drugs market is highly fragmented with many intravenous (IV) iron drugs market players operating worldwide. Some intravenous (IV) iron drugs market players operating on a local level while other players operating on a regional and global level. The manufacturers of intravenous (IV) iron drugs market produce intravenous iron drugs for different indications, with different iron content and in different doses.
However, the competition in the global intravenous (IV) iron drugs market is dominated by few intravenous iron drugs manufacturers. Further, key players of the intravenous (IV) iron drugs market are Vifor Pharma AG, Sanofi, AMAG Pharmaceuticals, Inc. and Daiichi Sankyo Co., Ltd. are also profiled with their financial information and respective business strategies.
Make an inquiry about this report @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1757459.
Country Coverage: The US & Europe
Iron is one of the most essential mineral found in the human body. About 70% of the iron in the body is present in the red blood cells, called hemoglobin. Hemoglobin is required in the body to transport oxygen throughout the body via the blood. Deficiency of iron in the human body leads to severe health problems, which are associated with morbidity and mortality. To maintain the required level of iron in the body, iron supplements are given to the patients.
Iron supplements can be given in two forms: oral iron drugs and intravenous (IV) iron drugs. Oral iron drugs can be in the form of capsules, tablets or liquid drops. Intravenous iron drugs are given by injecting iron directly inside the body with a needle through a vein.
Intravenous iron drugs are favorably more preferred over oral iron drugs due to less side effects profile (oral iron drugs are not tolerable for many patients due to the poor gastrointestinal side effect); greater efficacy & better absorption (intravenous iron drugs are transported to the bone marrow through blood without need for absorption in the gut) and ensuring more efficient treatment (intravenous therapy allows larger dose of treatment over a short period of time).
Get Discount @ https://www.reportsnreports.com/contacts/discount.aspx?name=1757459.
Intravenous iron drugs have a long history with continuously evolving new generation intravenous iron drugs. The intravenous (IV) iron drugs market can be segmented on the basis of product, type and indication.
The global intravenous (IV) iron drugs market has increased at a significant CAGR during the years 2013-2017 and projections are made that the market would rise in the next four years i.e. 2018-2022 tremendously. The intravenous (IV) iron drugs market is expected to increase due to aging population, growing chronic diseases, escalating diabetic population, rising number of patients with chronic kidney disease, surge in the number of people with cancer, etc. Yet the market faces some challenges such as shift from Erythropoietin Stimulating Agents (ESAs) to HIF inhibitors, side effects associated with the use of intravenous iron drugs, etc.
Few Points from List of Figures Provided in Global Intravenous (IV) Iron Drugs Market:
Table 1: Global Intravenous (IV) Iron Drugs Market Players: A Financial Comparison; 2017/2018
Table 2: Global Intravenous (IV) Iron Drugs Market Players: Product Comparison
Table 3: Global Intravenous (IV) Iron Drugs Market Players by FDA Drug Approval
Figure 1: Types of Iron Supplements
Figure 2: Main Clinical Indications for Intravenous (IV) Iron Treatment
Figure 3: Reasons Favoring Intravenous Iron Use Over Oral Iron
Figure 4: Side Effects and Complications
Figure 5: Intravenous Iron Drugs Segmentation by Product
Figure 6: Intravenous Iron Drugs Segmentation by Type
Figure 7: Intravenous Iron Drugs Segmentation by Indication
Figure 8: Global Iron Drugs Market by Value; 2017 (US$ Billion)
Figure 9: Global Iron Drugs Market by Segments; 2017 (Percentage, %)
Figure 10: Global Oral Iron Drugs Market by Value; 2017-2022 (US$ Million)
Figure 11: Global IV Iron Drugs Market by Value; 2013-2017 (US$ Billion)
Figure 12: Global IV Iron Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 13: Global IV Iron Drugs Market by Product; 2017 (Percentage, %)
Figure 14: Global IV Iron Drugs Market by Type; 2017 (Percentage, %)
Figure 15: Global IV Iron Drugs Market by Region; 2017 (Percentage, %)
Figure 16: Global Injectafer/Ferinject IV Iron Drugs Market by Value; 2016-2017 (US$ Million)
Figure 17: Global Injectafer/Ferinject IV Iron Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 18: Global Venofer IV Iron Drugs Market by Value; 2016-2017 (US$ Million)
Figure 19: Global Venofer IV Iron Drugs Market by Value; 2018-2022 (US$ Million)
Figure 20: Global Other IV Iron Drugs Market by Value; 2016-2017 (US$ Million)
Browse all latest pharmaceuticals market research reports @ https://www.reportsnreports.com/market-research/pharmaceuticals/.
Contact Info:
Name: Hrishikesh Patwardhan
Email: Send Email
Organization: ReportsnReports
Phone: + 1 888 391 5441
For more information, please visit https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1757459
Source: MarketersMedia
Release ID: 436390
Copyright © 1999-2013 SproutNews.com
